Incyte (INCY) Cash & Current Investments (2010 - 2026)
Incyte (INCY) reported Cash & Current Investments of $4.0 billion for Q1 2026, up 66.72% on a YoY basis from $2.4 billion in Q1 2025, and up 12.15% quarter-over-quarter from $3.6 billion in Q4 2025.
Incyte (INCY) Cash & Current Investments (2010 - 2026) Analysis & Trends
Incyte has reported Cash & Current Investments for 17 years, with the latest figure at $4.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 66.72% year-over-year to $4.0 billion; the trailing twelve-month figure through Mar 2026 stood at $4.0 billion (up 66.72% YoY), and the FY2025 full-year result was $3.6 billion, up 65.92% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $4.0 billion, up from $3.6 billion in the prior quarter.
- The five-year high for Cash & Current Investments was $4.0 billion in Q1 2026, with the low at $1.3 billion in Q3 2024.
- Historically, Cash & Current Investments has averaged $2.9 billion across 5 years, with a median of $3.0 billion in 2022.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 62.82% — and 2025, when it soared 124.09%.
- Incyte's Cash & Current Investments stood at $3.2 billion in 2022, then climbed by 12.88% to $3.7 billion in 2023, then plunged by 40.97% to $2.2 billion in 2024, then surged by 65.92% to $3.6 billion in 2025, then gained by 12.15% to $4.0 billion in 2026.
- The last three Cash & Current Investments figures came in at $4.0 billion (Q1 2026), $3.6 billion (Q4 2025), and $2.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 4.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.02 Bn |
| Dec 31, 2025 | 3.58 Bn |
| Sep 30, 2025 | 2.93 Bn |
| Jun 30, 2025 | 2.42 Bn |
| Mar 31, 2025 | 2.41 Bn |
| Dec 31, 2024 | 2.16 Bn |
| Sep 30, 2024 | 1.31 Bn |
| Jun 30, 2024 | 1.45 Bn |
| Mar 31, 2024 | 3.85 Bn |
| Dec 31, 2023 | 3.66 Bn |
| Sep 30, 2023 | 3.52 Bn |
| Jun 30, 2023 | 3.42 Bn |
| Mar 31, 2023 | 3.11 Bn |
| Dec 31, 2022 | 3.24 Bn |
| Sep 30, 2022 | 2.98 Bn |
| Jun 30, 2022 | 2.72 Bn |
| Mar 31, 2022 | 2.54 Bn |
| Dec 31, 2021 | 2.35 Bn |
| Sep 30, 2021 | 2.28 Bn |
| Jun 30, 2021 | 2.08 Bn |